AC Immune
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,306 | $990 | $1,137 | $25,485 |
Gross Profit | 1,306 | 990 | 1,137 | 25,485 |
EBITDA | -20,516 | -18,363 | -15,235 | 6,065 |
EBIT | -21,139 | -18,975 | -15,764 | 5,536 |
Net Income | -21,189 | -19,029 | -15,797 | 5,503 |
Net Change In Cash | 1,306 | 990 | 1,137 | 25,485 |
Free Cash Flow | -15,971 | -19,178 | 5,844 | -14,312 |
Cash | 25,722 | 19,960 | 36,275 | 32,417 |
Basic Shares | 100,631 | 100,408 | 100,858 | 100,858 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $27,309 | $14,801 | $3,935 | $944 |
Gross Profit | 27,309 | -39,805 | -56,401 | -62,282 |
EBITDA | -48,618 | -51,832 | -69,054 | -77,113 |
EBIT | -50,780 | -54,047 | -71,413 | -79,010 |
Net Income | -50,916 | -54,233 | -70,753 | -72,996 |
Net Change In Cash | 27,309 | 14,801 | 3,935 | 944 |
Free Cash Flow | 65,266 | -61,209 | -74,807 | -68,324 |
Cash | 36,275 | 78,494 | 31,586 | 82,216 |
Basic Shares | 99,692 | 84,694 | 83,554 | 74,951 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.16 |
